Opinion by
Cole, J.
It was stipulated that the merchandise in question is the same in all material respects as the estrogenic hormone passed upon in Roche-Organon, Inc. v. United States (35 C. C. P. A. 99, C. A. D. 378) The claim at 5 percent under paragraph 34, as modified by T. D. 51802, was therefore sustained.